Opioid prescribing: ‘We’ve been able to change the culture’
Christopher Corless, M.D., Ph.D.
Executive director and chief medical officer, Knight Diagnostic Laboratories, OHSU Knight Cancer Institute; Professor of pathology, OHSU School of Medicine. (OHSU)
Joe Gray, Ph.D.
Joe Gray, Ph.D., associate director for Biophysical Oncology, OHSU Knight Cancer Institute. (OHSU)
Gordon Mills, M.D., Ph.D.
Gordon Mills, M.D., Ph.D., at the Knight Cancer Research Center in Portland, September 13, 2018. (OHSU/John Valls)
Knight Cancer Institute researchers
Zahi Mitri, M.D., (left) talks with Gordon Mills, M.D., Ph.D., at the Knight Cancer Research Center in Portland, September 13, 2018. (OHSU/John Valls)
Making cancer clinical trials SMMART
Doernbecher Freestyle: 15 years of sole, nearly $24 million raised
Affordable health care means better access to diabetes prevention, management
Joe Gray, Ph.D.
Joe Gray, Ph.D.,(left) director of the OHSU Center for Spatial Systems Biomedicine (OCSSB) and the OHSU Knight Cancer Institute associate director for biophysical oncology, September 26, 2014. (OHSU/Chris Hornbecker)
Joe Gray, Ph.D.
Joe Gray, Ph.D., director of the OHSU Center for Spatial Systems Biomedicine (OCSSB) and the OHSU Knight Cancer Institute associate director for biophysical oncology, September 26, 2014. (OHSU/Chris Hornbecker)
